Joseph A Markenson, MD

Dr Markenson is Professor of Clinical Medicine, Joan and Sanford Weill Medical College of Cornell University. He is also an attending Physician at the Hospital for Special Surgery, the New York Hospital in New York, and Memorial Sloan-Kettering Cancer Center. 

Dr Markenson received his MD from the State University of New York, Downstate Medical Center, Brooklyn, and completed his internship at Kings County, at the same institution. He was a Medical Officer for the National Institutes of Health, Division of Biologics Laboratory of Viral Immunology, in Bethesda, MD, and completed his residency at Cornell University Medical Center, The New York Hospital. He also completed a fellowship in Rheumatology at the Hospital for Special Surgery, NY. 

Dr Markenson is a member of many boards and societies, including the American Association of Immunology, the American College of Physicians, the New York Academy of Medicine, the American Occupational Medical Association, the American College of Rheumatology, the New York Academy of Science, the American Society of Microbiology, the American Federation for Clinical Research, and the Society for Experimental Medicine and Biology. He has received many awards and honors, including being designated as a Diplomate for the American Board of Internal Medicine and the American Board of Internal Medicine Subspecialty Board of Rheumatology. He has also been named a Lupus Erythematosus Foundation Fellow and elected a Master of the American College of Rheumatology. 

Dr Markenson has had articles published in a number of scientific journals and his areas of research interest include immunology, microbiology, occupational medicine, and lupus. 

Selected references 

• Genovese, MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: Two-year radiographic and clinical outcomes. Arthritis Rheum 2002;46:1443–50. 
• Kremer JM, Genovese MC, Cannon GW, et al. Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial. Ann Int Med 2002;137:726–33. 
• Markenson J. New standards and methods of care for treating the arthritic patient. J Muscoskel Med 2001;18:S1–S56. 
• Pincus T, Koch GG, Sokka T, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587–98.
• Bathon,J.M.,Martin R.W. ,Fleischmann,R.M., Tesser,J.R.,Schiff,m.H.,Keystyone,E.C.,Genovese,M.C.,Moreland.L.M.,Weaver, A.l.,Markenson,J.M. and B.K.Finck. A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis.N.E.J.M.343:1586-1593,2000
• Markenson J.A. Guest Editor Rheumatic Disease Clinic of North America. Rheumatologic Manifestations of Endocrine Disease. Elsevier Volume 36,4,2010